- Pfizer pens $10B, 12-drug deal with Innovent in broad bet on Chinese cancer med innovation Fierce Biotech
- Pfizer and Innovent Biologics Enter Global Strategic Collaboration to Accelerate Development of Innovative Oncology Medicines Business Wire
- Pfizer strikes up to $10.5B deal with Chinese biotech Innovent Axios
- Innovent Biologics, Pfizer strike $10.5 bln cancer drug deal amid China biotech boom Reuters
- Innovent Biologics shares rise 10% after pact with Pfizer of up to $10.5 billion CNBC

Leave a Reply